The FDA has expanded the approval for Merck's Vaxneuvance for prevention of invasive disease caused by Streptococcus pneumoniae to include children 6 weeks through 17 years of age.
Women who receive COVID-19 mRNA vaccines during pregnancy pass high levels of antibodies to their babies, new research from NYU Langone shows.Read More
For the first time researchers have shown a link between lower lung function in babies born to physically inactive mothers compared to those born to active mothers.Read More
Women who use electronic cigarettes during pregnancy are 33% more likely than those who don’t to give birth to low-birthweight infants, according to a new study published in the journal Obstetrics & Gynecology.Read More
The FDA is expected to authorize the Pfizer/BioNTech COVID-19 vaccination for children ages 12-15 as early as this week, and the company plans to request authorization for ages 2-11 this fall.Read More
Pulse oximetry-based critical congenital heart disease screening using Masimo SET had higher CCHD screening sensitivity than physical exam.Read More
The interhospital transport of infants with persistent pulmonary hypertension of the newborn (PPHN) being administered inhaled nitric oxide therapy requires specialized, intensive care.Read More
Research suggests that compared to vaginally-born children, cesarean-born children may have a higher risk of infection-related hospitalization for up to five years of age.Read More